Singapore, Feb 08, 2010: Shanghai ChemPartner, a China-based contract research organization and a wholly owned subsidiary of ShangPharma, announced that it has received the 2009 Most Valuable Partner (MVP) Award from Roche R&D Center China (RRDCC) for excellent service and outstanding contributions in the area of oncology and diabetes pharmacology research, which have successfully helped advance the RRDCC drug discovery project milestones during 2009.

"We are honored to receive this award and appreciate Roche China's recognition of the efforts and dedication of our talented team of scientists. This award reflects the value and capabilities of ChemPartner's service to our partners," commented Mr Michael Hui, Founder and CEO of ChemPartner.

"We will continue to focus on the quality of our science, project management and logistics, to add value for our partners R&D programs. We are also committed to provide intellectual contributions to our customers and partners by leveraging the R&D expertise of our scientific team," said Dr Yuguang Wang, Senior VP of ChemPartner.

RRDCC MVP awards are presented annually to partners who have done excellent work in collaboration with RRDCC. More than 20 external partners were evaluated in this award competition of 2009.